Update
$Crinetics(CRNX.US$ Crinetics Announces Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid Syndrome
1 MINUTE AGO, 4:05 PM EST
VIA GLOBENEWSWIRE
1 MINUTE AGO, 4:05 PM EST
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment